10001 employees
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders.
2011
$15M
from 2 investors over 2 rounds
Tensha Therapeutics, Inc. raised undisclosed on April 26, 2012
Investors: Torrey Pines Investment
Tensha Therapeutics, Inc. raised $15M on September 12, 2011
Investors: HealthCare Ventures LLC